What’s Driving APAC’s Graft Market Growth by 2034?

The Asia Pacific Aortic Stent Graft Market is witnessing robust development as regional healthcare infrastructure evolves and demand for minimally invasive procedures rises. As per Expert Market Research, the global market size for aortic stent grafts was valued at USD 3.10 billion in 2024, with Asia Pacific holding a significant portion. The region is projected to grow at a CAGR of 5.80% from 2025 to 2034, reaching a value of approximately USD 5.45 billion by the end of the forecast period.

This growth trajectory reflects changing demographics, advancements in vascular treatments, and expanding public and private healthcare investments across the region.

Current Market Trends in Asia Pacific

One of the dominant market trends is the increasing preference for endovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR) techniques over traditional open surgeries. These minimally invasive techniques offer reduced recovery time and lower surgical risks, making them ideal for elderly patients—a demographic that is growing rapidly across Asia.

In countries like Japan, China, and India, demand is surging due to improved diagnostic capabilities and rising health awareness. The deployment of advanced imaging technologies such as CT angiography has also enabled more precise treatment planning, thereby supporting market expansion.

Another trend is the localization of manufacturing. Companies like MicroPort Scientific Corporation are focusing on regional production to reduce dependency on global supply chains and meet domestic regulatory standards more effectively.

Recent Case Studies and Market News

A notable development occurred in China, where regional health authorities approved newer-generation thoracic aortic stent graft systems manufactured by local firms. This move is intended to reduce costs and increase accessibility to life-saving vascular procedures.

Similarly, in India, several tier-one hospitals have reported successful case studies using hybrid endovascular techniques for high-risk patients. These outcomes are being documented in peer-reviewed journals, contributing to increased adoption across urban medical centers.

As per a Wikipedia overview of endovascular aneurysm repair, these procedures have significantly transformed the treatment landscape for aortic aneurysms, particularly in aging populations—a trend increasingly evident in Asia Pacific markets.

Key Market Drivers

Several factors are fueling the Asia Pacific Aortic Stent Graft Market:

• Aging Population: Rising life expectancy and an increasing elderly population predisposed to vascular diseases.
• Chronic Diseases: Higher incidence of hypertension, smoking, and genetic predispositions are contributing to aortic aneurysm cases.
• Technological Advancements: Enhanced imaging and stent graft design improve procedural success rates and reduce complication risks.
• Government Healthcare Initiatives: Countries such as Australia and Japan are expanding national insurance coverage to include EVAR and TEVAR procedures.

Major Industry Players

The regional market is characterized by a mix of multinational and domestic manufacturers. Key players include:

• Cook Medical, Inc.
• W.L. Gore & Associates
• MicroPort Scientific Corporation Inc.
• Medtronic Plc.
• Lombard Medical, Inc.
• Endologix, Inc.
• Terumo Corporation Inc.
• Cardinal Health Inc.
• Becton, Dickinson and Company
• CryoLife Inc.

These companies are continuously investing in research and development to improve device flexibility, deliverability, and compatibility with complex anatomies.

Market Segmentation Overview

By Product

• Abdominal Aortic Stent Grafts: Widely used for treating abdominal aortic aneurysms.
• Thoracic Aortic Stent Grafts: Gaining traction due to higher incidence of thoracic aneurysms in elderly populations.

By End User

• Hospitals: Dominating segment due to access to advanced surgical infrastructure.
• Ambulatory Surgical Centers: Growing rapidly, offering cost-effective and efficient care.
• Others: Includes specialty vascular clinics and academic medical centers.

By Region

• China: Leading market share with expanding domestic capabilities and aging demographics.
• Japan: High adoption of advanced medical technologies.
• ASEAN: Emerging market with improving healthcare access.
• Australia: Mature market driven by government funding and innovation.
• India: Fast-growing due to public health initiatives and rising disease burden.
• Others: Includes South Korea, Taiwan, and Hong Kong.

Future Growth Potential

Looking ahead, the Asia Pacific Aortic Stent Graft Market is poised for continued growth. As healthcare systems focus on preventive care and early diagnosis, the demand for elective aneurysm repairs is likely to rise. Innovations such as drug-eluting stent grafts and bioresorbable materials may also reshape the competitive landscape in the long term.

Moreover, strategic partnerships between global leaders and regional distributors will be essential for expanding market access in underpenetrated areas. Training programs aimed at vascular surgeons and interventional radiologists will further drive procedural adoption.